Helix Acquisition Corp. II
IPO Proceeds, $M | $184.00M |
---|---|
IPO Date | Feb 9, 2024 |
CEO | Bihua Chen |
Left Lead | Leerink Partners |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
Healthcare
Biotechnology sector |
IPO Geography | US/Canada |
Target Company | TBD |
Deal Announced | TBD |
Deal Size, $M | TBD |
Deal Sector | TBD |
Deal Geography | TBD |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | TBD |
Price | $10.55 |
---|---|
Last closing price | $10.55 |
H/L, today | $10.50 / $10.65 |
Volume, today | 8,008 |
Volume, 3-month avg. | N/A |
No credit card required
Sign in for more on Helix Acquisition Corp. II:
- Structure and cap table
- 5 directors & officers
- 5 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Bihua Chen | 55 | Chairperson and Chief Executive Officer |
Caleb Tripp | 38 | Chief Financial Officer |
Nebojsa Obradovic | 53 | Chief Legal Officer |
John Schmid | 60 | Director |
Mark McKenna | 44 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Leerink Partners | BR | 16,000,000 | units |
16,000,000 | units | ||
Up-Front UW fee | 1.00 | % | |
Deferred UW fee |
3.00 | % |
Sign in to view more advisor data.
Filings
Jan 18, 2024 | Initial S-1 |
Feb 2, 2024 |
Amended S-1
Sign In to view filing content. |
Feb 9, 2024 |
PR announcing pricing of upsized $160mm IPO
Sign In to view filing content. |
Feb 13, 2024 | 424B4 IPO Prospectus |
Feb 14, 2024 |
8-K announcing full over-allotment exercise
Sign In to view filing content. |